ATP7B and metabolic syndrome: Based on a review of the literature, it is hypothesized that dyslipidemia in WD patients may be linked to copper overload and its effects on lipid metabolism-related pathways, as well as the modulation of intestinal lipid metabolism by ATP7B (17).